EMA — authorised 19 June 2019
- Marketing authorisation holder: L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A.
- Status: approved
EMA authorised Subutex on 19 June 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 19 June 2019.
L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A. holds the EU marketing authorisation.